MoonLake Immunotherapeutics (MLTX)
12.34
+0.41
(+3.44%)
USD |
NASDAQ |
Oct 28, 16:00
12.69
+0.35
(+2.84%)
After-Hours: 17:53
MoonLake Immunotherapeutics Market Cap : 1.032B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 997.43M |
| October 26, 2026 | 987.40M |
| October 23, 2026 | 990.74M |
| October 22, 2026 | 1.032B |
| October 21, 2026 | 890.41M |
| October 20, 2026 | 862.82M |
| October 19, 2026 | 815.17M |
| October 16, 2026 | 798.44M |
| October 15, 2026 | 857.80M |
| October 14, 2026 | 847.77M |
| October 13, 2026 | 870.35M |
| October 12, 2026 | 892.92M |
| October 09, 2026 | 904.62M |
| October 08, 2026 | 884.56M |
| October 07, 2026 | 900.44M |
| October 06, 2026 | 915.49M |
| October 05, 2026 | 951.44M |
| October 02, 2026 | 953.95M |
| October 01, 2026 | 958.97M |
| September 30, 2026 | 978.20M |
| September 29, 2026 | 957.30M |
| September 28, 2026 | 966.49M |
| September 25, 2026 | 1.007B |
| September 24, 2026 | 1.013B |
| September 23, 2026 | 1.079B |
| Date | Value |
|---|---|
| September 22, 2026 | 1.119B |
| September 21, 2026 | 1.049B |
| September 18, 2026 | 1.036B |
| September 17, 2026 | 1.033B |
| September 16, 2026 | 1.042B |
| September 15, 2026 | 1.020B |
| September 14, 2026 | 1.060B |
| September 11, 2026 | 1.046B |
| September 10, 2026 | 1.102B |
| September 09, 2026 | 1.147B |
| September 08, 2026 | 1.249B |
| September 04, 2026 | 1.255B |
| September 03, 2026 | 1.270B |
| September 02, 2026 | 1.259B |
| September 01, 2026 | 1.265B |
| August 31, 2026 | 1.258B |
| August 28, 2026 | 1.253B |
| August 27, 2026 | 1.298B |
| August 26, 2026 | 1.306B |
| August 25, 2026 | 1.301B |
| August 24, 2026 | 1.285B |
| August 21, 2026 | 1.318B |
| August 20, 2026 | 1.327B |
| August 19, 2026 | 1.400B |
| August 18, 2026 | 1.366B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 945.73M |
| Santhera Pharmaceuticals Holding AG | 274.57M |
| BeOne Medicines Ltd. | 38.90B |
| AC Immune SA | 215.91M |
| CRISPR Therapeutics AG | 5.231B |
Market Cap Related Metrics
| PEG Ratio | -0.0859 |
| Price to Book Value | 2.409 |
| Price | 12.34 |
| Earnings Yield | -31.08% |
| PEGY Ratio | -0.0859 |